AI Verdict
ABT has stronger fundamentals based on our AI analysis.
ABT vs CI Fundamental Comparison
| Metric | ABT | CI |
|---|---|---|
| Revenue | $44.3B | $274.9B |
| Net Income | $6.5B | $6.0B |
| Net Margin | 14.7% | 2.2% |
| ROE | 12.5% | 14.3% |
| ROA | 7.5% | 3.8% |
| Current Ratio | 1.58x | 0.85x |
| Debt/Equity | 0.25x | 0.74x |
| EPS | $3.72 | $22.18 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
ABT vs CI: Frequently Asked Questions
Is ABT or CI a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), ABT has stronger fundamentals. ABT is rated BUY (77% confidence) while CI is rated BUY (76% confidence). This is not investment advice.
How does ABT compare to CI fundamentally?
ABBOTT LABORATORIES has ROE of 12.5% vs Cigna Group's 14.3%. Net margins are 14.7% vs 2.2% respectively.
Which stock pays higher dividends, ABT or CI?
ABT has a dividend yield of N/A or no dividend while CI has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in ABT or CI for long term?
For long-term investing, consider that ABT has BUY rating with 77% confidence, while CI has BUY rating with 76% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about ABT vs CI?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For ABT vs CI, the AI consensus favors ABT based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.